Cao Z, Sui E, Wu Y. Behavior and Consequences of COVID-19-related Voluntary Disclosure: Evidence from Pharmaceutical Companies. BCPBM [Internet]. 2022 Nov. 5 [cited 2026 Jun. 24];31:378-91. Available from: https://bcpublication.org/index.php/BM/article/view/2653